Elacridar tilonium Bromide [1] The active substance is

[1] The active substance is tenofovir

Smiles: CN(C)C/C=C/C(=O)NC1C=CC(=CC=1)C(=O)NC1=CC(=CC=C1)NC1=NC(=C(Cl)C=N1)C1=CNC2=CC=CC=C21

Approved API for cancer therapeutic use is doxorubicin HCl

6-tetrahydropyrimidine-4-carboxylic acid

Elacridar tilonium Bromide [1] The active substance isElacridar, also known as GF120918A, is a P glycoprotein (P gp) inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. In vitro, GF120918A demonstrated high plasma protein binding across species, although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse, rat, and dog